You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PDL injection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Gastric Cancer Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), Nivolumab

Recruiting
  • Metastatic Gastric Cancer
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • Nivolumab Injection
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Aug 23, 2023

Primary Hepatocellular Carcinoma Trial (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), camrelizumab for

Not yet recruiting
  • Primary Hepatocellular Carcinoma
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • camrelizumab for Injection
  • (no location specified)
Nov 13, 2023

Cervical Cancer Trial in Wuhan (Recombinant humanized anti-PD-1 mAb injection, Cisplatin, Bevacizumab Injection)

Not yet recruiting
  • Cervical Cancer
  • Recombinant humanized anti-PD-1 monoclonal antibody injection
  • +4 more
  • Wuhan, Hubei, China
    Tongji Hospital affiliated to Tongji Medical College of Huazhong
Nov 3, 2023

Sarcoma Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))

Recruiting
  • Sarcoma
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)
  • Beijing, China
    Peking University People's Hospital
Nov 6, 2023

Chemo, Radiation Therapy Trial in Fuzhou (Camrelizumab, Paclitaxel, Cisplatin)

Not yet recruiting
  • Chemotherapy
  • Radiation Therapy
  • Fuzhou, China
    Fujian Medical University Union Hospital
Apr 6, 2023

Advanced Pancreatic Cancer Trial in Hangzhou (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)) in

Recruiting
  • Advanced Pancreatic Cancer
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)) in combination with Nivolumab
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
Mar 8, 2022

Cancer, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Stage III Trial in Worldwide (Durvalumab Injection)

Recruiting
  • Cancer
  • +4 more
  • Durvalumab Injection
  • Tallinn, Estonia
  • +9 more
Dec 1, 2021

Primary Liver Cancer Trial in Hangzhou (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)))

Recruiting
  • Primary Liver Cancer
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of Med
Apr 21, 2021

Advanced Malignant Solid Tumor Trial in ShangHai (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)))

Recruiting
  • Advanced Malignant Solid Tumor
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • ShangHai, Shanghai, China
  • +1 more
Apr 26, 2021

Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Scottsdale,

Active, not recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +7 more
  • Scottsdale, Arizona
  • +2 more
Nov 3, 2021

Root Canal Infection Trial in Cairo (local anesthesia)

Completed
Has Results
  • Root Canal Infection
  • local anesthesia
  • Cairo, Egypt
    Ain Shams University
Oct 5, 2021

Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)

Recruiting
  • Solid Tumor Malignancy
  • +4 more
  • mRNA-1273
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 14, 2023

Advanced Tumors Trial in Jinan, Shanghai (PM1022)

Recruiting
  • Advanced Tumors
  • Jinan, Shandong, China
  • +1 more
May 10, 2023

Edematous Fibrosclerotic Panniculopathy (EFP), Cellulite Trial in United States (QWO™(CCH-aaes) + No Mitigation Treatment,

Completed
  • Edematous Fibrosclerotic Panniculopathy (EFP)
  • Cellulite
  • QWO™(CCH-aaes) + No Mitigation Treatment
  • +5 more
  • Scottsdale, Arizona
  • +7 more
Nov 2, 2021

Melanoma Trial in Worldwide (Pembrolizumab Dose C, Pembrolizumab Dose A, Pembrolizumab Dose B)

Active, not recruiting
  • Melanoma
  • Pembrolizumab Dose C
  • +3 more
  • Orange, New South Wales, Australia
  • +14 more
Jan 19, 2023

Prostate Cancer Trial run by the NCI (PROSTVAC-V/F, Nivolumab)

Recruiting
  • Prostate Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 12, 2022

Advanced Solid Tumor Trial in China (Envofolimab, BD0801, Docetaxel)

Recruiting
  • Advanced Solid Tumor
  • Beijing, China
  • +24 more
Apr 2, 2022

Advanced or Metastatic Solid Tumors Trial in Worldwide (MK-3475A, Pembrolizumab, Pemetrexed)

Active, not recruiting
  • Advanced or Metastatic Solid Tumors
  • MK-3475A
  • +7 more
  • Santiago, Region M. De Santiago, Chile
  • +14 more
Aug 10, 2022

Port Wine Stains Trial in Irvine (Combined Photodynamic & Pulsed Dye Laser Treatment)

Completed
Has Results
  • Port Wine Stains
  • Combined Photodynamic & Pulsed Dye Laser Treatment
  • Irvine, California
    Beckman Laser Medical Clinic,University
Oct 19, 2022

Rosacea Trial in Hamburg (532nm KTP, 585nm PDL)

Recruiting
  • Rosacea
  • 532nm KTP
  • 585nm PDL
  • Hamburg, Germany
    Laser Department, University Medical-Center Hamburg-Eppendorf
Mar 5, 2023

Stage IV NSCLC Trial in Houston (Poly ICLC, IVIG)

Not yet recruiting
  • Stage IV NSCLC
  • Houston, Texas
    Michael E. DeBakey VA Medical Center, Houston, TX
Sep 28, 2023

Orthodontic Retention Trial in Alexandria (Extended maxillary fixed retainer)

Completed
  • Orthodontic Retention
  • Extended maxillary fixed retainer
  • Alexandria, Egypt
    Faculty of dentistry , Alexandria university
Jun 3, 2023

Lung Cancer, Liver Cancer, Colorectal Cancer Trial in Guangzhou (ipilimumab +pembrolizumab +durvalumab)

Recruiting
  • Lung Cancer
  • +10 more
  • ipilimumab +pembrolizumab +durvalumab
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Jan 10, 2022

Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial (VG161)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Intrahepatic Cholangiocarcinoma
  • (no location specified)
Mar 22, 2022

NSCLC, HNSCC, Melanoma Trial (CJRB-101, Pembrolizumab injection)

Not yet recruiting
  • NSCLC
  • +5 more
  • (no location specified)
Jun 1, 2023